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Abstract
Background: The allocation of any scarce health care resource, especially a lifesaving resource, can create profound
ethical and legal challenges. Liver transplant allocation currently is based upon urgency, a sickest-first approach,
and does not utilize capacity to benefit. While urgency can be described reasonably well with the MELD system,
benefit encompasses multiple dimensions of patients’ well-being. Currently, the balance between both principles is
ill-defined.
Methods: This survey with 502 participants examines how urgency and benefit are weighted by different stakeholders
(medical staff, patients on the liver transplant list or already transplanted, medical students and non-medical university
staff and students).
Results: Liver transplant patients favored the sickest-first allocation, although all other groups tended to favor benefit.
Criteria of a successful transplantation were a minimum survival of at least 1 year and recovery of functional status to
being ambulatory and capable of all self-care (ECOG 2). An individual delisting decision was accepted when the 1-year
survival probability would fall below 50%. Benefit was found to be a critical variable that may also trigger the
willingness to donate organs.
Conclusions: The strong interest of stakeholder for successful liver transplants is inadequately translated into current
allocation rules.
Keywords: Liver transplantation, Allocation, Urgency, Utility, Willingness to donate, Legal aspects, Quality of life, Ethics,
Prospect of success, Benefit
Background
Organ allocation often implies life and death decisions
and thus has to be based on medically reasonable and
ethically justified grounds. Liver allocation systems
currently rely on algorithms focusing on urgency, a
sickest-first approach. In an optimal case an urgency-
driven allocation system would offer an organ at an opti-
mal time point in the course of the disease and no
waiting list deaths would occur. At present we are far
from optimal.
In 2006 the Model of End-Stage Liver Disease (MELD)
allocation system was adopted in Germany. The MELD
score is an urgency-based quantifiable allocation system
based only upon serum total bilirubin, serum creatinine
and the international normalized ratio (INR) and corre-
lates well with wait-list mortality [1–3]. After MELD
introduction in Germany, the average MELD score for a
regular liver allocation went up from 25 to meanwhile
34. Although higher MELD scores are associated with
increased waitlist mortality, post-transplant survival is
decreased with MELD scores > 30 [3, 4].
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Overall post-transplant survival has thus decreased in
Germany, triggering a discussion that capacity to benefit
should be integrated into liver transplant allocation algo-
rithms [5, 6]. At present this discussion is ongoing and
implies not only medical considerations, but also ethical,
legal and social aspects.
With this survey we wanted to describe how urgency
and benefit are weighted by the stakeholders in order to
enrich the discussion how these two criteria should be
balanced in a liver allocation system.
Methods
Respondents
The survey was conducted on 4 separate groups: 1) Med-
ical staff consisting of physicians and surgeons, nurses and
medical assistants working to various degrees in trans-
plantation medicine. Participants were approached during
morning conferences and asked to anonymously fill out a
paper-and-pencil questionnaire; 2) Patients with end-stage
liver disease (ESLD) who either had received a liver trans-
plant or were listed for a transplant. These patients were
asked to fill out the questionnaire while waiting in the
transplant outpatient clinic; 3) Medical students in their
third to fifth year, who were approached at University after
their lecture; and 4) Non-medical university staff and stu-
dents, who were approached by a web-based survey tool.
The response rate of the paper-based survey was 70.4%
(342 of 486 questionnaires completed and returned) which
was used for groups 1–3. Information was missing in 17
questionnaires that prohibited categorization to one of the
above mentioned groups and thus were excluded from
analysis. For group 4, non-medical university staff and
students were approached using an online survey tool
(LimeSurvey) linked to the university information service
and subscribed by 5489 users. The online questionnaire
was answered by 115 respondents from group 4. There
also were 28 additional respondents from group 1 and 34
from group 3 who completed the online survey. In total,
there were 502 completed surveys available for analysis.
In group 1 (medical staff ) 24 participants worked at
the hospital and studied medicine, in group 2 (patients),
7 patients pointed out to have a medical background.
Three patients waiting for a re-transplant were catego-
rized in the pre-transplant group.
Data were collected from February to July 2015. A
declaration of no-objection for the survey was granted
by the ethics committee of the LMU Munich.
Study design
In preparation of the survey, a pilot survey was per-
formed with 3 persons of each group to ensure reading
comprehensibility. The final product contained 7 quantita-
tive survey questions regarding capacity to benefit in liver
transplantation and additional 4 questions regarding the
national liver allocation system in Germany (not
included in this publication). Following the survey
questions, basic demographic information was ob-
tained from participants that may influence the
attitude towards organ transplantation, including age,
gender, the highest level of education, working in the
field of transplantation medicine, medical profession
(physician, medical assistant, nurse and medical stu-
dent), patient status (post-transplant or listed for
transplant), current state of health, smoking, body
mass index (BMI), and religiosity [6–9].
Analysis
Data were analyzed using SPSS Statistics 23 (IBM
Corporation, Armonk, New York, USA). An ordinal lo-
gistic regression model (proportional odds model) was
used to analyze the influence of personal factors on the
balance of urgency and benefit. For analysis the five point
scale was contracted. Due to missing answers, the sample
size for the regression analysis decreased to n = 397. Vari-
ables with a significant difference of p < 0.25 were selected
for the ordinal regression. P-values (Wald-test) of p < 0.05
were considered significant. The sample size was sufficient
to perform the analysis on the above mentioned influen-
cing factors [10].
Results
The study population including the subgroups is
depicted in Fig. 1. Group 1 (medical staff ) included more
medical assistants and nurses but less physicians. In
group 2 (ESLD patients) the majority of respondents had
already undergone a liver transplant.
Demographics are shown in Table 1. Group 2 (ESLD
patients) were older, had a lower performance status,
lower education level, but they generally tended to be
more religious as compared to the remaining groups 1,
3 and 4.
Fig. 1 Classification of respondents
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Criteria for success: Gain in lifetime and gain in quality of
life
In your opinion, what is the criterion for success in liver
transplantation? (Possible answers: 1) Gain in lifetime,
2) Gain in quality of life, or 3) Both lifetime and quality
of life).
The vast majority of respondents stated that both –
gain in lifetime and gain in quality of life – are criteria
for success (436/502 = 86.9%). Surprisingly, there was a
considerable portion of 20.0% (23/115) of respondents in
group 4 (non-medical persons) who emphasized only
gain in quality of life.
Gain in lifetime
Let’s suppose that gain in lifetime is a criterion for
success: How long at a minimum should a patient sur-
vive after transplantation in order to call it “successful”?
(Possible answers: several hours, several days, 3 months,
1 year, 5 years, or 10 years).
Table 1 Personal data, n (%)
Medical staff Patients Medical students Non-medical persons Total of respondents
Mean age 31.8 55.2 23.1 30.3 32.0; Range: 19–80
Gender
Male 40 (38.8) 69 (67.6) 68 (37.6) 34 (29.6) 211 (42.1)
Female 63 (61.2) 33 (32.4) 113 (62.4) 81 (70.4) 290 (57.9)
Current state of health
ECOG 0 99 (97.1) 34 (34.3) 177 (98.3) 109 (94.8) 419 (84.5)
ECOG 1 3 (2.9) 39 (39.4) 2 (1.1) 6 (5.2) 50 (10.1)
ECOG 2 0 (0.0) 24 (24.2) 1 (0.6) 0 (0.0) 25 (5.0)
ECOG 3 0 (0.0) 2 (2.0) 0 (0.0) 0 (0.0) 2 (0.4)
ECOG 4 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Smoking
Yes 19 (18.4) 17 (16.5) 14 (7.7) 6 (5.2) 56 (11.2)
No 84 (81.6) 86 (83.5) 167 (92.3) 109 (94.8) 446 (88.8)
Body mass index
< 18.5 1 (1.1) 3 (3.2) 7 (3.9) 10 (8.8) 21 (4.4)
18.5–24.9 70 (74.5) 41 (43.2) 155 (87.1) 75 (66.4) 341 (71.0)
25–29.9 16 (17.0) 32 (33.7) 16 (9.0) 21 (18.6) 85 (17.7)
>/= 30 7 (7.4) 19 (20.0) 0 (0.0) 7 (6.2) 33 (6.9)
Highest completed level of education
Basic secondary (Hauptschule) 1 (1.0) 39 (39.8) 1 (0.6) 1 (0.9) 42 (8.5)
Advanced secondary (Realschule) 14 (13.9) 27 (27.6) 0 (0.0) 4 (3.5) 45 (9.1)
Final secondary (Hochschulreife) 32 (31.7) 9 (9.2) 159 (88.8) 52 (45.2) 252 (51.1)
College (Fachhochschule) 11 (10.9) 10 (10.2) 3 (1.7) 5 (4.3) 29 (5.9)
University (Universität) 43 (42.6) 13 (13.3) 16 (8.9) 53 (46.1) 125 (25.4)
Considering oneself a religious person
Yes 54 (52.9) 72 (74.2) 91 (51.7) 58 (50.4) 275 (56.1)
No 48 (47.1) 25 (25.8) 85 (48.3) 57 (49.6) 215 (43.9)
Working in the field of transplantation medicine
Yes 53 (51.5) 0 (0.0) 16 (8.8) 0 (0.0) 69 (13.9)
No 50 (48.5) 99 (100.0) 165 (91.2) 115 (100.0) 429 (86.1)
Willingness to donate organs
Yes 84 (82.4) 92 (92.0) 149 (82.8) 85 (73.9) 410 (82.5)
No 14 (13.7) 4 (4.0) 13 (7.2) 11 (9.6) 42 (8.5)
I do not know 4 (3.9) 4 (4.0) 18 (10.0) 19 (16.5) 45 (9.1)
Englschalk et al. BMC Medical Ethics  (2018) 19:7 Page 3 of 10
Collectively, a minimum survival of 1 year after a liver
transplant was the most common choice to classify the
transplant as successful (181/493 = 36.7%). Interestingly,
medical staff and patients had higher expectations on
the outcome of a transplant procedure;10 year sur-
vival was the most common interval chosen by patients
(39/98 = 39.8%) and 5 year survival was the most common
interval chosen by medical staff (44/102 = 43.1%).The
answers are detailed in Fig. 2.
Performance status
Let’s suppose that gain in quality of life is a criterion for
success: Which quality of life regarding independence
and mobility would you expect at a minimum after
transplantation in order to call it “successful”? (Possible
answers based on the well-defined ECOG performance
status from ECOG 0 (fully active, all performance with-
out restriction) to ECOG 4 (completely disabled, totally
confined to bed or chair) [11]).
To call a liver transplant successful, most respondents ex-
pected a performance status of ECOG 2 (ambulatory and
capable of all self-care, but unable to carry out any work ac-
tivities − 204/495 = 41.2%), or ECOG 1 (restricted in physic-
ally strenuous activity but ambulatory and able to carry out
work of a light or sedentary nature - 173/495 = 34.9%).
Respondents generally did not accept a state of disability
and poor self-care; only few respondents chose ECOG 3
(capable of only limited self-care and confined to bed or
chair more than 50% of waking hours - 61/495 = 12.3%) or
ECOG 4 (3/495 = 0.6%).
Patients had higher postoperative performance expec-
tations as compared to all other groups; the most
frequent answer was ECOG 1 (40/99 = 40.4%), followed
by ECOG 0 (30/99 = 30.3%). All results are presented
in Fig. 3.
Acceptance of delisting
As donor organs are limited, not all patients requiring a
liver transplantation can be transplanted. At which risk
of dying within 1 year after transplantation would you –
as patient on the waiting list – accept delisting? (Possible
answers ranged from a probability of death of 0% to
100%).
Delisting from the waiting list was generally accepted
beginning with a post-transplant mortality risk of 50%.
Numerically, the most common interval where respon-
dents accepted delisting was a probability of death of
70–80% (174/492 = 35.4%). Again, patients answered dif-
ferently as compared to the other groups. Most patients
were willing to accept extremely poor outcomes; they
did not accept being taken off the waiting list until a
mortality risk of 90–100% (34/96 = 35.4%). See Fig. 4 for
all results.
Urgency versus prospect of success – a dilemma
According to the German Transplant Law, prospect of
success and urgency shall be considered in the organ allo-
cation system (§ 12 (3) TPG). A balance between both
interests is difficult to achieve in liver transplantation,
due to the scarcity of donor organs: The most urgent pa-
tients are seriously ill when they receive the donor
organ. Even if, in a first step, the transplantation has
been successful, their survival afterwards is inferior. Pa-
tients with good prospect of success are, in most cases,
Fig. 2 Gain in lifetime as criterion for “successful” liver transplantation
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not as sick yet. Therefore, they are not as urgent. They
better cope with the transplantation and their survival is
better. Should the most urgent patient - the one whose
probability of death without transplantation is highest -
get the next available organ in any case? Or should the
patient with the best prospect of success - the one who
statistically can survive for the longest period of time with
the transplanted organ - get the next donor organ? Please
weigh these two interests. (Urgency and prospect of suc-
cess could be weighed across a five-point scale).
The most common response was a tendency to favor
prospect of success (182/495 = 36.8%). Again, patients
responded differently as compared to the other groups,
voting for a balance of the two interests (34/98 = 34.7%)
or urgency (24/98 = 24.5%) more often than the other
groups. All results are displayed in Fig. 5.
Fig. 3 Gain in quality of life as criterion for “successful” liver transplantation
Fig. 4 Acceptance of delisting with a probability of death of 0% to 100%
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Influence of personal factors on the balance of urgency
and prospect of success
We examined a possible influence of personal factors on
the balance of urgency and prospect of success with an
ordinal logistic regression analysis. Three variables had a
statistically significant effect on the decision. First, per-
sons working in the field of transplantation medicine
were more likely to favor prospect of success compared
to persons not working in the field (Wald = 13.474,
p < 0.001, OR 0.24, 95% CI: 0.11 to 0.51). Second,
smokers were more likely to consider urgency than non-
smokers (Wald = 5.879, p = 0.015, OR 2.23, 95% CI: 1.17
to 4.28) and patients were more likely to consider urgency
than non-medical persons (Wald = 4.220, p = 0.040, OR
2.69, 95% CI: 1.05 to 6.91).
Other personal factors such as age, gender or educa-
tion had no statistically significant effect on the balance
between urgency and prospect of success in our survey.
Influence of prospect of success on willingness to donate
organs
First, participants were asked if they were currently
willing to donate their organs after death. Patients were
more willing to donate their organs after death than
participants of all other groups. All results can be seen
in Table 1.
Does the prospect of success of the performed trans-
plantations influence your decision whether or not to
donate your organs after your death? If influence yes: In
what way? (Possible answers: I would like to donate my
organs only/rather if they are given to patients with a
high prospect of success/urgency).
Most respondents denied that an influence of prospect
of success would affect their willingness to donate or-
gans (349/489 = 71.4%). Interestingly, 28.6% (140/489) of
the respondents affirmed an influence of prospect of
success would affect their willingness to donate. The lat-
ter were asked how prospect of success influenced their
decision. The great majority rather wanted to donate
their organs if they were given to patients with a high
prospect of success (87/134 = 64.9%). See Figs. 6 and 7
for all results.
Discussion
Benefit in liver transplantation is the focus of this survey.
The goal was to investigate the role of capacity to benefit
in the allocation system of liver grafts. It is challenging
to allocate organs in times of organ shortage from a
medical, ethical and legal standpoint. The problem of
organ shortage is exacerbated in Germany by the fact
that organ donation numbers are lower than in other
countries [12]. Several allocation criteria are discussed
and the question arises whether a satisfying balance can
be found between them. Allocation of liver grafts com-
petes with two principles: urgency and capacity to bene-
fit. Urgency of need is also known as the “sickest-first”
principle. In this case, the most urgent patient, the one
whose probability of death without transplantation is
highest, gets the next available organ. These patients are
extremely ill when they receive the donor organ, which
often negatively impacts post-transplant survival. In con-
trast, benefit focuses on patients who have the better
post-transplant survival. In most cases, these patients
are not as ill at the time of transplantation [5, 13, 14].
Fig. 5 Urgency versus prospect of success – a dilemma
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The question arises whether and to what extent benefit
should be weighted in a liver allocation system. Adding
benefit to the liver allocation system is currently limited
by the lack of an accurate quantitative measure of the
benefit criteria. Diverse definitions or target criteria of
benefit exist [5, 15]. Benefit is best understood as an
utilitarian concept as a criterion that favors the
maximization of net benefit for the highest possible
number of patients. This general rule, however, can be
operationalized in different ways, for example, save the
most lives of individual patients, save the most life years
of the group of patients [5, 13, 16, 17] or maximize the
survival benefit of them (difference of lifetime with vs.
without a liver transplant) [18–23]. The German
Transplant Law does not define benefit. Guidelines of
the German Medical Association (GMA) specify the
German Transplant Law. These guidelines define benefit
as longer-term sufficient transplant function translating
into a longer-term survival of the recipient with an
improved quality of life [2].
We investigated the GMA definition of benefit, focus-
ing on longer-term survival and improved quality of life.
Fig. 6 Influence of prospect of success on willingness to donate organs
Fig. 7 If influence yes: I would like to donate my organs only/rather if given to patients with high prospect of success/urgency
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The vast majority of survey respondents chose gain in
lifetime and gain in quality of life as the fundamental
criteria of successful liver transplantation. The aim was
to find out what longer-term survival and improved
quality of life means for the different groups. This survey
shows that affected patients, medical staff, medical stu-
dents and non-medical university staff and students had
a clear and relatively uniform idea about benefit in liver
transplantation. The majority of respondents considered
liver transplantation successful if there was a gain in life-
time of more than a year. Compared to non-medical
persons, the medical staff and patients even had higher
expectations with at least a five or 10 year increased sur-
vival, respectively.
An important dimension of quality of life is the ability
to live a self-determined, independent life. We have
based our question on the definition of the ECOG per-
formance status [11] in order to facilitate a description
of the abstract concept “quality of life”. Most respon-
dents expected a performance status with at most ECOG
2. Being ambulatory and capable of all self-care was im-
portant to call a liver transplant successful. Interestingly,
liver transplant patients had the highest postoperative
performance status expectations.
The current MELD-based liver allocation system only
adopts the urgency principle [1, 2]. This current practice
of allocating livers was confirmed by previous studies on
allocation criteria that found a preference for urgency-
based allocation [6, 7, 14, 24, 25]. Some legal scholars
suggest that urgency is the only category which should be
used for allocation of life chances [16, 26]. Our results
show that liver transplant patients favor the sickest-first
allocation, although all other groups (medical staff,
medical students, and non-medical participants) tended to
favor benefit.
Previous studies on allocation criteria demonstrated
that both – urgency and capacity to benefit – were im-
portant factors within an allocation system, some giving
priority to benefit [9, 27–30]. According to the German
Transplant Law, “Erfolgsaussicht” (literally translated as
prospect of success) and urgency shall be considered
(§ 12 (3) TPG). It has to be noted that prospect of suc-
cess and capacity to benefit are mutually interchangeable.
Benefit is more frequently used internationally. A commit-
tee of the German Medical Association determines spe-
cific allocation guidelines for each organ, specifying the
German Transplant Law. In contrast to the current liver
allocation system, the lung allocation scheme incorporates
benefit in addition to urgency in Germany. The lung allo-
cation system is based on the Lung Allocation Score
(LAS), which weighs both aspects in the allocation algo-
rithm. Benefit is integrated through taking into account
the estimated survival probability and projected duration
of 1-year survival with or without a lung transplantation
[31, 32]. The US has recently adopted a utility-based allo-
cation system for kidney transplantation as well based
upon the Estimated Post-Transplant Survival (EPTS) scor-
ing system. Therefore, benefit is incorporated through tak-
ing into account the estimated post-transplant survival
[33]. Similar to the LAS and EPTS, most respondents in
this study wanted both urgency and benefit criteria incor-
porated in the liver allocation system. In fact, several of
the survey groups (medical staff, medical students and
non-medical persons) favored benefit over urgency.
Benefit not only affects the allocation of liver grafts,
but also influences (de) listing decisions. In times of
organ shortage, not all patients requiring a transplant
can be transplanted. We were interested whether re-
spondents would accept a delisting decision when their
mortality risk exceeds a defined threshold. Most respon-
dents would only accept delisting with a 1-year mortality
risk of 50%, significantly higher than the 25% 1-year
post-liver transplant mortality observed in Germany
[12]. One common survival “rule of thumb” is greater
than 50% chance of 5-year survival post-transplant
utilized in North America and Europe [23, 34–36], UK
[30, 34] and Australia [14]. Currently, German delisting
criteria for defining patients as “too ill” for transplant
are not yet established. After Germany adopted the
MELD score, there was a significant increase in the pro-
portion of liver transplants performed on critically ill
hospitalized patients. Early outcomes of liver transplant-
ation declined precipitously [3, 12].
The final issue of this survey was the connection be-
tween benefit and the willingness to donate organs.
Transplantation medicine has to rely on the general
public’s willingness to donate organs. The general public
needs to be represented in liver allocation decisions to
achieve an accepted and supported allocation system
[30, 37–39]. Previous studies showed a difference be-
tween the general public’s and the medical staff ’s opin-
ion [6, 37, 40] and only few studies approached the
patient’s expectations and success criteria for liver trans-
plantations [41, 42].
We asked whether benefit in liver transplantation
would have an impact on the willingness to donate or-
gans. Almost 30% of all respondents claimed that benefit
would be a critical factor for their willingness to donate
their organs.
This study shares limitations common to survey-based
studies including representativeness and generalizability.
This single center study consisted of university staff and
students, which may not be an adequate sample of the
general population. On average, respondents were youn-
ger and better educated than members of the general
public. Also, the survey was limited to urgency of need
and capacity to benefit. Other factors relevant for organ
allocation such as time on the waiting list or reciprocity
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were not included. Finally, there were no tests of
reliability or validity on the survey instrument.
Conclusions
Despite these limitations, there are several conclusions
that can be drawn from this survey: 1) the majority of
respondents wanted benefit to be considered in the liver
allocation algorithm; 2) liver transplant recipients were
expected to recover to the state of being ambulatory and
capable of all self-care (ECOG 2); 3) at least a 1-year sur-
vival was expected; 4) most respondents would accept a
delisting decision when the probability of death would
exceed 50% within the first year after transplantation;
and 5) benefit may be a critical variable that triggers a
person’s willingness to donate organs.
Although there is more research to be done to define
and conceptualize the idea of benefit in liver transplant-
ation, the present study may serve to stimulate the dis-
cussion about allocation criteria and the consideration of
benefit both in medicine and society.
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